Patrick J. Stiff

26.2k total citations · 5 hit papers
247 papers, 8.4k citations indexed

About

Patrick J. Stiff is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Patrick J. Stiff has authored 247 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Oncology, 120 papers in Hematology and 69 papers in Pathology and Forensic Medicine. Recurrent topics in Patrick J. Stiff's work include Hematopoietic Stem Cell Transplantation (84 papers), Lymphoma Diagnosis and Treatment (64 papers) and Acute Myeloid Leukemia Research (35 papers). Patrick J. Stiff is often cited by papers focused on Hematopoietic Stem Cell Transplantation (84 papers), Lymphoma Diagnosis and Treatment (64 papers) and Acute Myeloid Leukemia Research (35 papers). Patrick J. Stiff collaborates with scholars based in United States, Canada and Italy. Patrick J. Stiff's co-authors include Auayporn Nademanee, Ivana N. Micallef, John F. DiPersio, Richard T. Maziarz, Gary Bridger, Tawee Tanvetyanon, John M. McCarty, Brian J. Bolwell, Gary Calandra and Richard I. Fisher and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Patrick J. Stiff

236 papers receiving 8.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

2004 606 citations Patrick J. Stiff, Daniel J. Weisdorf et al. profile →
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

2009 579 citations John F. DiPersio, Auayporn Nademanee et al. Blood profile →
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

2009 512 citations John F. DiPersio, Ivana N. Micallef et al. Journal of Clinical Oncology profile →
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

2015 477 citations Auayporn Nademanee, Patrick J. Stiff et al. profile →
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

2013 460 citations Patrick J. Stiff et al. Blood profile →

Peers

Countries citing papers authored by Patrick J. Stiff

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Stiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Stiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Stiff more than expected).

Fields of papers citing papers by Patrick J. Stiff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Stiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Stiff. The network helps show where Patrick J. Stiff may publish in the future.

Co-authorship network of co-authors of Patrick J. Stiff

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick J. Stiff. A scholar is included among the top collaborators of Patrick J. Stiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick J. Stiff. Patrick J. Stiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3. 2024 ·Journal of Clinical Oncology ·Olalekan O. Oluwole, Armin Ghobadi, Ryan D. Cassaday, Jae H. Park, Roch Houot, Aaron C. Logan, Nicolas Boissel, Thibaut Leguay, Michael Bishop, Max S. Topp, (unknown), Maria R. Baer, Gary J. Schiller, Mehrdad Abedi, Monique C. Minnema, Patrick J. Stiff, (unknown), (unknown), (unknown), Bijal Shah	3
2	Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice 2023 ·Cancers ·Patrick J. Stiff, Swati Mehrotra, Ronald K. Potkul, (unknown), Christopher J. Walker, Maureen L. Drakes	4
3	Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease 2023 ·Transplantation and Cellular Therapy ·(unknown), Lisa M. Minter, Anne I. Sperling, (unknown), Phong T. Le, Barbara A. Osborne, Shubin Zhang, Patrick J. Stiff, Katherine L. Knight	2
4	Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy 2023 ·Transplantation and Cellular Therapy ·Paul Szabolcs, Roei David Mazor, Dima Yackoubov, Stuart B. Levy, Patrick J. Stiff, Andrew R. Rezvani, Rabi Hanna, John E. Wagner, Amy K. Keating, Caroline A. Lindemans, Nicole Karras, Joseph P. McGuirk, Nelson Hamerschlak, (unknown), Guillermo Sanz, David Valcárcel, Mitchell E. Horwitz	6
5	Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients 2023 ·Transplantation and Cellular Therapy ·Patricia Mumby, William Adams, Scott E. Smith, Murali Rao, Patrick J. Stiff	1
6	SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA 2023 ·Hematological Oncology ·Brian Hess, (unknown), Nasheed Hossain, Volkan Beylergil, Craig S. Sauter, Mehdi Hamadani, Jakub Svoboda, Ajay Major, Brad S. Kahl, John P. Leonard, Sonali M. Smith, Michael LeBlanc, Patrick J. Stiff, Jonathan W. Friedberg	3
7	Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplant with Omidubicel Demonstrates Sustained Clinical Improvement Versus Standard Myeloablative Umbilical Cord Blood Transplantation (UCBT): Final Results of a Phase III Randomized, Multicenter Study 2022 ·Transplantation and Cellular Therapy ·Mitchell E. Horwitz, Patrick J. Stiff, Corey Cutler, Claudio G. Brunstein, Andrew R. Rezvani, Rabi Hanna, William Ying Khee Hwang, Richard T. Maziarz, Joseph P. McGuirk, Nicole Karras, Caroline A. Lindemans, David Valcárcel, Liang Piu Koh, Gary J. Schiller, Jaime Sanz, (unknown), (unknown), Guillermo Sanz	1
8	Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood 2022 ·Transplantation and Cellular Therapy ·Chenyu Lin, Gautam Sajeev, Patrick J. Stiff, Claudio G. Brunstein, Corey Cutler, Guillermo Sanz, Caroline A. Lindemans, Andrew R. Rezvani, Rabi Hanna, Liang Piu Koh, Richard T. Maziarz, William Ying Khee Hwang, Yan Song, Qing Liu, (unknown), (unknown), James Signorovitch, Mitchell E. Horwitz, Anthony D. Sung	3
9	Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) 2021 ·Blood ·Susan E. Prockop, Kris M. Mahadeo, Amer Beitinjaneh, Sylvain Choquet, Patrick J. Stiff, Ran Reshef, Gowri Satyanarayana, Saurabh Dahiya, Hema Parmar, Wei Ye, Laurence Gamelin, Rajani Dinavahi	8
10	Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation 2021 ·Bone Marrow Transplantation ·Coco de Koning, Weiyang Tao, (unknown), (unknown), Mitchell E. Horwitz, Guillermo Sanz, Madan Jagasia, John E. Wagner, Patrick J. Stiff, Rabi Hanna, Daniela Cilloni, David Valcárcel, Tony Peled, (unknown), (unknown), Aridaman Pandit, Caroline A. Lindemans, Jaap Jan Boelens, Stefan Nierkens	3
11	Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma 2016 ·Biology of Blood and Marrow Transplantation ·Tulio E. Rodriguez, Parameswaran Hari, Patrick J. Stiff, Scott E. Smith, (unknown), David H. Vesole	25
12	Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy 2014 ·ImmunoTargets and Therapy ·Maureen L. Drakes, Patrick J. Stiff	12
13	Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496) 2012 ·Journal of Clinical Oncology ·Leo I. Gordon, Fangxin Hong, Richard I. Fisher, Nancy L. Bartlett, Joseph M. Connors, Randy D. Gascoyne, Henry Wagner, Patrick J. Stiff, Bruce D. Cheson, Mary Gospodarowicz, Ranjana H. Advani, Brad S. Kahl, Jonathan W. Friedberg, Kristie A. Blum, Thomas M. Habermann, Joseph M. Tuscano, Richard T. Hoppe, Sandra J. Horning	194
14	A human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells 2011 ·Experimental Hematology ·Britte Beaudette-Zlatanova, Katherine L. Knight, Shubin Zhang, Patrick J. Stiff, Juan Carlos Zúñiga‐Pflücker, Phong T. Le	16
15	Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma breakdown → 2009 ·Journal of Clinical Oncology ·John F. DiPersio, Ivana N. Micallef, Patrick J. Stiff, Brian J. Bolwell, Richard T. Maziarz, Eric D. Jacobsen, Auayporn Nademanee, John M. McCarty, Gary Bridger, Gary Calandra	512
16	Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial 2008 ·Leukemia & lymphoma ·Sucha Nand, John E. Godwin, Scott E. Smith, Kevin Barton, Laura C. Michaelis, Serhan Alkan, (unknown), Karen Rychlik, (unknown), Patrick J. Stiff	46
17	Allogeneic hematopoietic cell transplantation for metastatic breast cancer 2007 ·Bone Marrow Transplantation ·Naoto T. Ueno, J. Douglas Rizzo, Taner Demirer, Yee Chung Cheng, Ute Hegenbart, M-J Zhang, Marco Bregni, Angelo Michele Carella, Didier Blaise, Asad Bashey, Jacob D. Bitran, Brian J. Bolwell, Gerald J. Elfenbein, (unknown), César O. Freytes, Robert Peter Gale, Hillard M. Lazarus, Richard E. Champlin, Patrick J. Stiff, Dietger Niederwieser	47
18	The administration of polymerized human hemoglobin (pyridoxylated) to a jehovah's witness after submyeloablative stem cell transplantation complicated by delayed graft failure 2006 ·Comprehensive Therapy ·Scott E. Smith, Amir A. Toor, Tulio E. Rodriguez, Patrick J. Stiff	8
19	AMD3100 plus G-CSF rapidly mobilizes hematopoietic progenitor cells in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM), including those traditionally considered “poor mobilizers” 2005 ·Biology of Blood and Marrow Transplantation ·Patrick J. Stiff, (unknown), Philip L. McCarthy, Margarida Magalhaes‐Silverman, (unknown), Daniel J. Weisdorf, Guido Tricot, Mary Territo, (unknown), Karin Badel, Gary Calandra	1
20	Graft-versus-host disease of the skin: life and death on the epidermal edge 2004 ·Biology of Blood and Marrow Transplantation ·Craig C. Hofmeister, (unknown), Kenneth R. Cooke, Patrick J. Stiff, Brian J. Nickoloff, James L.M. Ferrara	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact